| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.007 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.009 |